Correction: An International Adult Guideline for Making Clozapine Titration Safer                    by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine                    Levels

de Leon, Jose; Schoretsanitis, Georgios; Smith, Robert L.; Molden, Espen; Solismaa, Anssi; Seppälä, Niko; Kopeček, Miloslav; Švancer, Patrik; Olmos, Ismael; Ricciardi, Carina; Iglesias-Garcia, Celso; Iglesias-Alonso, Ana; Spina, Edoardo; Ruan, Can-Jun; Wang, Chuan-Yue; Wang, Gang; Tang, Yi-Lang; Lin, Shih-Ku; Lane, Hsien-Yuan; Kim, Yong Sik; Kim, Se Hyun; Rajkumar, Anto P.; González-Esquivel, Dinora F.; Jung-Cook, Helgi; Baptista, Trino; Rohde, Christopher; Nielsen, Jimmi; Verdoux, Hélène; Quiles, Clelia; Sanz, Emilio J.; De Las Cuevas, Carlos; Cohen, Dan; Schulte, Peter F.J.; Ertuğrul, Aygün; Anıl Yağcıoğlu, A. Elif; Chopra, Nitin; McCollum, Betsy; Shelton, Charles; Cotes, Robert O.; Kaithi, Arun R.; Kane, John M.; Farooq, Saeed; Ng, Chee H.; Bilbily, John; Hiemke, Christoph; López-Jaramillo, Carlos; McGrane, Ian; Lana, Fernando; Eap, Chin B.; Arrojo-Romero, Manuel; Rădulescu, Flavian Ş.; Seifritz, Erich; Every-Palmer, Susanna; Bousman, Chad A.; Bebawi, Emmanuel; Bhattacharya, Rahul; Kelly, Deanna L.; Otsuka, Yuji; Lazary, Judit; Torres, Rafael; Yecora, Agustin; Motuca, Mariano; Chan, Sherry K.W.; Zolezzi, Monica; Ouanes, Sami; De Berardis, Domenico; Grover, Sandeep; Procyshyn, Ric M.; Adebayo, Richard A.; Kirilochev, Oleg O.; Soloviev, Andrey; Fountoulakis, Konstantinos N.; Wilkowska, Alina; Cubała, Wiesław J.; Ayub, Muhammad; Silva, Alzira; Bonelli, Raphael M.; Villagrán-Moreno, José M.; Crespo-Facorro, Benedicto; Temmingh, Henk; Decloedt, Eric; Pedro, Maria R.; Takeuchi, Hiroyoshi; Tsukahara, Masaru; Gründer, Gerhard; Sagud, Marina; Celofiga, Andreja; Ignjatovic Ristic, Dragana; Ortiz, Bruno B.; Elkis, Helio; Pacheco Palha, António J.; LLerena, Adrián; Fernandez-Egea, Emilio; Siskind, Dan; Weizman, Abraham; Masmoudi, Rim; Mohd Saffian, Shamin; Leung, Jonathan G.; Buckley, Peter F.; Marder, Stephen R.; Citrome, Leslie; Freudenreich, Oliver; Correll, Christoph U.; Müller, Daniel J.

doi:10.1055/a-1737-1527

All Outputs (7)

PROF. MUHAMMAD SHAFIQUE (1936-2022): PIONEER OF PSYCHIATRY IN KHYBER PAKHTUNKHWA, PAKISTAN (2022)
Journal Article
Farooq, S. (2022). PROF. MUHAMMAD SHAFIQUE (1936-2022): PIONEER OF PSYCHIATRY IN KHYBER PAKHTUNKHWA, PAKISTAN. Khyber Medical University Journal, 14(3), 213-214. https://doi.org/10.35845/kmuj.2022.23161

Cluster A personality disorders and potential for early intervention in psychosis: Challenges and opportunities (2022)
Book Chapter
Farooq, S., & Ayub, M. (2022). Cluster A personality disorders and potential for early intervention in psychosis: Challenges and opportunities. In Psychosis and Personality Disorders (87-105). Springer. https://doi.org/10.1007/978-3-031-09058-5_5

The ‘Cluster A’ personality disorders consist of paranoid, schizoid and schizotypal personality disorders. The common features of personality disorders in this cluster are social awkwardness, social withdrawal, odd or eccentric behaviour and distorte... Read More about Cluster A personality disorders and potential for early intervention in psychosis: Challenges and opportunities.

Patients’ and healthcare professionals’ perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study (2022)
Journal Article
Ishaq Khattak, M., Dikomitis, L., Firaz Khan, M., Ul Haq, M., Saeed, U., Riaz Awan, N., …Farooq, S. (2022). Patients’ and healthcare professionals’ perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study. PloS one, https://doi.org/10.1371/journal.pone.0273286

OBJECTIVE: To explore the perceptions and experiences of schizophrenia from patients, their care givers, health care providers, spiritual and traditional healers to develop a community-based intervention for improving treatment adherence for people w... Read More about Patients’ and healthcare professionals’ perspectives on a community-based intervention for schizophrenia in Pakistan: A focus group study.

Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia (2022)
Journal Article
Farooq, S., Hattle, M., Dazzan, P., Kingstone, T., Ajnakina, O., Shiers, D., …Van Der Windt, D. (in press). Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia. BMJ Open, 12(4), https://doi.org/10.1136/bmjopen-2021-056420

ABSTRACTIntroductionTreatment Resistant Schizophrenia (TRS) is associated with significant impairment of functioning and high treatment costs. Identification of patients at high risk of TRS at their initial diagnosis may significantly improve clinica... Read More about Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia.

Impact of COVID-19 on mental health research: is this the breaking point? (2022)
Journal Article
Sparasci, O., Bhui, K., Biswas, A., Chamberlain, S., Dubicka, B., Dudas, R., …Young, A. (2022). Impact of COVID-19 on mental health research: is this the breaking point?. British Journal of Psychiatry, 220(5), 254-256. https://doi.org/10.1192/bjp.2022.8

Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia (2022)
Other
Farooq, S., Hattle, M., Dazzan, P., Kingstone, T., Ajnakina, O., Shiers, D., …van der Windt, D. A. (2022). Study protocol for the development and internal validation of SPIRIT (Schizophrenia Prediction of Resistance to Treatment): A clinical tool for predicting risk of treatment resistance to anti-psychotics in First Episode Schizophrenia. [PREPRINT]

Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (2022)
Journal Article
de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., …Müller, D. J. (2022). Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry, 55(02), e1-e1. https://doi.org/10.1055/a-1737-1527